Hims & Hers Health, Inc.
NYSE:HIMS
16.57 (USD) • At close September 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Revenue
| 872 | 526.916 | 271.878 | 148.757 | 82.558 | 26.679 |
| Cost of Revenue
| 166.566 | 118.194 | 67.384 | 39.307 | 37.953 | 18.876 |
| Gross Profit
| 705.434 | 408.722 | 204.494 | 109.45 | 44.605 | 7.803 |
| Gross Profit Ratio
| 0.809 | 0.776 | 0.752 | 0.736 | 0.54 | 0.292 |
| Reseach & Development Expenses
| 48.227 | 29.237 | 22.379 | 11.238 | 0 | 0 |
| General & Administrative Expenses
| 129.883 | 98.192 | 183.634 | 65.605 | 55.863 | 28.002 |
| Selling & Marketing Expenses
| 446.435 | 272.587 | 135.902 | 58.989 | 63.156 | 55.57 |
| SG&A
| 738.895 | 370.779 | 319.536 | 124.594 | 119.019 | 83.572 |
| Other Expenses
| 7.882 | 77.403 | 0.445 | -11.238 | 1.858 | 0 |
| Operating Expenses
| 738.895 | 477.419 | 319.536 | 124.594 | 119.019 | 83.575 |
| Operating Income
| -33.461 | -68.697 | -115.042 | -15.144 | -74.414 | -75.769 |
| Operating Income Ratio
| -0.038 | -0.13 | -0.423 | -0.102 | -0.901 | -2.84 |
| Total Other Income Expenses Net
| 11.89 | 2.988 | 4.247 | -2.843 | 2.44 | 0.563 |
| Income Before Tax
| -21.571 | -65.709 | -110.795 | -17.987 | -71.974 | -75.206 |
| Income Before Tax Ratio
| -0.025 | -0.125 | -0.408 | -0.121 | -0.872 | -2.819 |
| Income Tax Expense
| 1.975 | -0.031 | -3.136 | 0.127 | 0.09 | 0.037 |
| Net Income
| -23.546 | -65.678 | -107.659 | -18.114 | -72.064 | -75.243 |
| Net Income Ratio
| -0.027 | -0.125 | -0.396 | -0.122 | -0.873 | -2.82 |
| EPS
| -0.11 | -0.32 | -0.58 | -0.51 | -2.86 | -1.12 |
| EPS Diluted
| -0.11 | -0.32 | -0.58 | -0.51 | -2.86 | -1.12 |
| EBITDA
| -23.946 | -61.223 | -110.522 | -16.92 | -72.296 | 0.563 |
| EBITDA Ratio
| -0.027 | -0.116 | -0.407 | -0.114 | -0.876 | 0.021 |